New York, NY, July 25, 2016 Researchers found no significant differences in health related quality of life between patients with low risk prostate cancer on active surveillance and men without the disease over 3 years of followup, according to new study in the Journal of Urology ELSEVIER HEALTH SCIENCES [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Active surveillance…
Date: July 11, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] It is a well-known fact that men with a family history of prostate cancer run an increased risk of developing the disease. The risk for brothers of men with prostate cancer is doubled. But a doubled risk of what, exactly? Prostate cancer my be an indolent condition…
GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier February 10 GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined…
Researchers Look to MRI and Biomarkers to Help Improve Detection of Aggressive Prostate Cancers January 28, 2015 A patient’s wife once told urology surgeon…
Scientific Cooperation Aims to Accelerate Transfer of High Quality Prostate MRI from Laboratories to Clinics December 1, 2014, Chicago, IL– The Joint Steering Committee of the American College of Radiology (ACR), AdMeTech Foundation and the European Society of Urogenital Radiology (ESUR) today released new clinical imaging guidelines to assist early detection and treatment of prostate…
Oncologist Dr. Samir Taneja, right, and radiologist Dr. Andrew Rosenkrantz review an MRI ahead of a prostate biopsy at NYU Langone Medical Center. NYU LANGONE MEDICAL CENTER SUMATHI REDDY Nov. 3, 2014 5:12 p.m. ET Every Friday and Monday, Samir Taneja conducts about six biopsies at NYU Langone Medical Center in New York to diagnose…